Upcoming GW4 AMR Alliance events
AMR ALLIANCE BID DeVelopMent AND NEtworking EvENT
A 2-day in-person event is planned for 6-7th April 2022 in Cardiff. An initial, online event was held on January 13-14 2022
The event is open to all GW4 investigators (eligible to lead on/apply for funding) working in all aspects of antimicrobial resistance or more broadly in the themes we will be focusing on. The aim of this event is to bring AMR Alliance members and GW4 investigators together to start new conversations, develop ideas and bid proposals across 4 cross-disciplinary One Health AMR themes (see below) to develop innovations to help prevent and control AMR.
We particularly encourage all those interested/working in the following areas to participate:- (please note that the event subheadings are only indicative and not exclusive)
1. One Health prevention and control of AMR in the built and urban environment: e.g. hospital, healthcare, social care, housing, agricultural or public transport settings; with vulnerable or impoverished people; in urban settings involving industrial waste, pollution and wastewater management; urban parks/farms where humans and animals meet or co-exist; digital health, joined up healthcare and AMR surveillance tools, technologies & systems; building design and other interventions (e.g. combatting biofilms on contact surfaces or novel antimicrobial materials/products) to help prevent the transmission of antimicrobial-resistant bacteria; messaging and communication in public health policy and education.
The event would be of particular interest to those who (i) aim to understand or modify how people and/or animals interact within indoor or urban outdoor settings; (ii) study the fates and flows of human or animal wastes, including associated sociocultural norms and policies; (iii) have expertise in infectious disease dynamics or infection control; (iv) are developing tools, technologies, or methodologies potentially applicable to these research areas.
2. One Health prevention and control in natural and farmed environments e.g. rural/natural environments; water systems and relationships with humans and animals; reservoirs of AMR and antibiotic residues; hydrological and hydrodynamic models; engineering and wastewater management to reduce transmission of resistant bacteria and resistance genes into human and animal populations (wildlife, livestock, fishes, and companion animals); impact of climate change (extreme weather events exacerbating AMR e.g. flood events, drought).
The event would be of particular interest to those who: i) aim to identify the environmental reservoirs of AMR in water, soil and air and/or their social drivers ; ii) study the emergence of resistance genes from the environmental resistome; iii) study the interactions between environmental and human and animal associated AMR bacteria; iv) are developing tools to measure the impact of antimicrobial residues on AMR evolution, the management of microbial and chemical pollution and the impact of climate change on AMR evolution and transmission; v) are developing mitigation strategies and environmental policy
3. One Health prevention and control of AMR in food, crop and industrial production systems: e.g. food security; plant pathogens and crop diseases; mitigating the impact of climate change on crop diseases an crop failure; AMR improving the efficacy, specificity, delivery and combinations and/or repurposing plant protection agents; reducing AMR bacteria in the food chain and industrial production systems; social drivers; policy development and interventions to prevent AMR disrupting food supplies particularly in respect to climate change
The event would be of particular interest to those who: i) aim to ensure our global food security, mitigating the impact of crop diseases and crop failure (particularly in respect to climate change); ii) study plant pathogens and crop diseases and are working to improve the efficacy, specificity, delivery and combinations and/or repurposing plant protection agents; iii) are developing ways to reduce resistant bacteria in the food chain and industrial production systems identifying social drivers, developing policies and interventions to prevent the emergence and spread of AMR
4. One Health prevention and control of AMR in co-infections, polymicrobial communities and microbiomes under pressure: e.g. microbial (bacterial/fungal/viral) co-infections (e.g cystic fibrosis, biofilms) – understanding and improving the detection/diagnosis and treatment of mixed infections; improving the efficacy, specificity, delivery and combinations and/or repurposing of drugs; complex polymicrobial communities (human, animal and environment) re. evolution and drivers of AMR; vaccine development and new drug targets; social drivers of microbial community composition and changes in microbiomes/risk of AMR
The event would be of particular interest to those who (i) aim to understand the behaviour of microbes in co-infections and the consequences in terms of host responses and antimicrobial resistance; (ii) aim to improve the detection and management of co-infections; (iii) are developing new combination therapies, repurposing of drugs, identifying new drug or vaccine targets; (iv) have expertise in studying complex polymicrobial communities under pressure (human, animal and environment)
For any enquiries, please contact email@example.com